Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.36 | €3.64 | 167.971% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €17.10 | €12.06 | -29.450% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.82 | - | - |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.95 | €8.35 | 328.789% |
| Ocular Therapeutix Inc. | 14 | 4 | 0 | 0 | €7.76 | €13.09 | 68.722% |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| Affimed N.V. | 12 | 6 | 0 | 0 | €0.55 | €6.61 | 1095.570% |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | €1.73 | €3.03 | 75.704% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €40.60 | €50.00 | 23.153% |
| Abeona Therapeutics Inc. | 6 | 1 | 2 | 0 | €4.72 | €19.31 | 309.100% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 34.172% |
| Viking Therapeutics Inc | 5 | 0 | 0 | 0 | €60.74 | - | - |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €103.85 | - | - |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | €82.50 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €54.00 | €50.00 | -7.407% |
| Pulmatrix Inc. | 3 | 1 | 2 | 0 | €1.82 | €6.08 | 233.901% |
| Aclaris Therapeutics Inc | 1 | 0 | 0 | 0 | €1.29 | €3.00 | 133.463% |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €18.82 | €20.00 | 6.298% |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | €151.00 | €241.54 | 59.963% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.94 | €6.45 | 231.924% |
| WAVE Life Sciences Ltd | 9 | 0 | 0 | 0 | €5.80 | €14.05 | 142.172% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.94 | €5.55 | 88.898% |
| Intellia Therapeutics Inc | 17 | 1 | 0 | 0 | €24.40 | €60.53 | 148.092% |
| Syros Pharmaceuticals Inc. | 7 | 1 | 0 | 0 | €5.60 | €13.70 | 144.702% |
| iRhythm Technologies Inc | 13 | 0 | 1 | 0 | €87.50 | €121.75 | 39.148% |